CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

SYLA Technologies Co., Ltd. engages in the operation of property investment platform. Its asset management platform includes Rimawari-kun and Rimawari-kun Pro. Rimawari-kun targets individual, in which this platform to facilitate real estate crowdfunding as well as the purchase and sale of real estate, sale of solar power plants which it constructs, and sale of computers. Rimawari-kun Pro targets corporate investors, institutional investors, and high-net-worth individuals. It exhibits properties on this platform as well as wide range of properties from other companies. Its business also includes asset management, including leasing, brokerage, and management of real estate, and operation and maintenance of solar power plants. The company was founded on March 3, 2009 and is headquartered in Tokyo, Japan.

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

a.k.a. Brands Holding Corp. engages in the provision of a portfolio of online fashion products through its digital platform. It operates through the Online and Stores business segments. The Online segment offers fashion products through Culture Kings. The Stores segment provides retail services. The company was founded on May 19, 2021 and is headquartered in San Francisco, CA.

Mediaco Holding, Inc. is a radio broadcasting media company. Its purpose is to acquire and operates radio stations and its associated assets located in New York. The firm operates through Radio and Outdoor Advertising segments. The company was founded in June 2019 and is headquartered in Indianapolis, IN.

Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device, In Vitro Diagnostics, and Corporate. The Medical Device segment designs, develops, and manufactures vascular interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment is composed of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.

Rocky Brands, Inc. engages in the design, manufacture, and marketing of footwear and apparel. Its brands include Rocky, Georgia Boot, Durango, Lehigh, and Michelin. It operates through the following segments: Wholesale, Retail, and Contract Manufacturing. The Wholesale segment distributes products through retail stores. The Retail segment includes direct sales of products to consumers through e-commerce websites, third party marketplaces, and Rocky outlet stores. The Contract Manufacturing segment focuses on wholesale, retail business and footwear contracts with the U.S. military. The company was founded in 1932 and is headquartered in Nelsonville, OH.

New York Community Bancorp, Inc. is a bank holding company, which engages in the provision of multi-family loans on non-luxury rent-regulated buildings that feature below-market rents. It also offers financial products and services to individuals and businesses. The company was founded on July 20, 1993 and is headquartered in Westbury, NY.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered New Romney, the United Kingdom.

Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded on November 21, 2018 and is headquartered in San Diego, CA.